149
Views
3
CrossRef citations to date
0
Altmetric
Original Articles: Basic Research

Spotlight on the three main hepatic fibrogenic cells in HCV-infected patients: Multiple immunofluorescence and ultrastructure study

, PhD, , MD, , MSc, , MD, , MD, , PhD & , MD show all
Pages 276-287 | Received 13 May 2016, Accepted 23 May 2016, Published online: 13 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sarah Hassan, Soheir S Mansy, Sahar A Tabak, Ahmed S AbdelFattah, Ahmed M Abdel-Aziz, Olfat Hamam, Mohammed I Seleem & Amr Abdelaal. (2018) Immunohistochemical and electron microscopic morphometric image analysis of hepatocellular carcinoma in association of HCV infection. Ultrastructural Pathology 42:2, pages 97-107.
Read now
Soheir S. Mansy, Eman El-Ahwany, Soheir Mahmoud, Sara Hassan, Mohammed I. Seleem, Amr Abdelaal, Ahmed H. Helmy, Mona K. Zoheiry, Ahmed S. AbdelFattah & Moataz H. Hassanein. (2017) Potential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients. Ultrastructural Pathology 41:3, pages 209-226.
Read now

Articles from other publishers (1)

Ranya M. El-Sheikh, Soheir S. Mansy, Iris G. Nessim, Hala N. Hosni, Ali El Hindawi, Moataz H. Hassanein & Ahmed S. AbdelFattah. (2019) Carbamoyl phosphate synthetase 1 (CPS1) as a prognostic marker in chronic hepatitis C infection. APMIS 127:2, pages 93-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.